Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q2 2020 Earnings

13AugExpected
Q2 2019
Q3 2019
Q1 2020
Q2 2020
-31.5
-21.2
-10.9
-0.6

Details

Expected EPS
-18
Actual EPS
-31.5
Surprise EPS
-13.5
Surprise Percent
+75%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -31.5 per share for Q2 2020.

0 Comments

Share your thoughts